Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients

Author： Salgo M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.5, 2000-11, pp. : 295-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

By Ernst D   Eisenhauer Elizabeth   Wainman Nancy   Davis Mary   Lohmann Reinhard   Baetz Tara   Belanger Karl   Smylie Michael  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 569-575

Springer Publishing Company

Access to resources Recommend Favorite

Tenofovir Plus Didanosine as Nrti Backbone in HIV-Infected Subjects

By  

Current Medicinal Chemistry, Vol. 13, Iss. 23, 2006-10 ,pp. : 2789-2793

Bentham Science Publishers

Access to resources Recommend Favorite

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

By Valeria Cavalcanti Rolla  

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 469-479

Adis International

Access to resources Recommend Favorite

Zidovudine plus caesarean section reduces HIV transmission risk

By  

Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Menstrual Cycle and Zidovudine Pharmacokinetics in HIV-Infected Women

By Mohammedebid A.I.  

Clinical Drug Investigation, Vol. 21, Iss. 10, 2001-10 ,pp. : 715-726

Adis International

Access to resources Recommend Favorite